A U.S. biotech company has received permission from an Institutional Review Board in the U.S. and India to experiment on 20 brain dead patients to determine if they can restart their brains.
A U.S. biotech company has received permission from an Institutional Review Board in the U.S. and India to experiment on 20 brain dead patients to determine if they can restart their brains.
